Innoviva (INVA) EPS (Basic) Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,207.14% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 440.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 440.54% |
| Dec 31, 2025 | -22.07% |
| Sep 30, 2025 | 6,400.00% |
| Jun 30, 2025 | 283.64% |
| Mar 31, 2025 | -227.59% |
| Dec 31, 2024 | -67.14% |
| Sep 30, 2024 | -98.41% |
| Jun 30, 2024 | -2,850.00% |
| Mar 31, 2024 | 13.73% |
| Dec 31, 2023 | 32.21% |
| Sep 30, 2023 | -66.93% |
| Jun 30, 2023 | 100.00% |
| Mar 31, 2023 | 121.74% |
| Dec 31, 2022 | -101.22% |
| Sep 30, 2022 | 266.35% |
| Jun 30, 2022 | -99.01% |
| Mar 31, 2022 | -75.27% |
| Dec 31, 2021 | -113.91% |
| Sep 30, 2021 | 271.43% |
| Jun 30, 2021 | 32.89% |
| Mar 31, 2021 | 43.08% |
| Dec 31, 2020 | 17.78% |
| Sep 30, 2020 | -28.21% |
| Jun 30, 2020 | 105.41% |
| Mar 31, 2020 | 96.97% |
| Dec 31, 2019 | -82.76% |
| Sep 30, 2019 | -17.02% |
| Jun 30, 2019 | -31.48% |
| Mar 31, 2019 | 13.79% |
| Dec 31, 2018 | 374.55% |
| Sep 30, 2018 | 113.64% |
| Jun 30, 2018 | 63.64% |
| Mar 31, 2018 | 81.25% |
| Dec 31, 2017 | 129.17% |
| Sep 30, 2017 | 57.14% |
| Jun 30, 2017 | 153.85% |
| Mar 31, 2017 | 300.00% |
| Dec 31, 2016 | 500.00% |
| Sep 30, 2016 | 450.00% |
| Jun 30, 2016 | 285.71% |
| Mar 31, 2016 | 144.44% |
| Dec 31, 2015 | 128.57% |
| Sep 30, 2015 | 78.95% |
| Jun 30, 2015 | 61.11% |
| Mar 31, 2015 | 40.00% |
| Dec 31, 2014 | 69.57% |
| Sep 30, 2014 | -111.11% |
| Jun 30, 2014 | 51.35% |
| Mar 31, 2014 | -36.36% |
| Dec 31, 2013 | -35.29% |
| Sep 30, 2013 | 75.68% |
| Jun 30, 2013 | 11.90% |
| Mar 31, 2013 | -110.89% |
| Dec 31, 2012 | 24.44% |
| Sep 30, 2012 | 0.00% |
| Jun 30, 2012 | -35.48% |
| Mar 31, 2012 | 460.71% |
| Dec 31, 2011 | -80.00% |
| Sep 30, 2011 | -27.59% |
| Jun 30, 2011 | -10.71% |